The DOI matches its Crossref record; 264 of the 268 references it cites were found in a registry or an index.
Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine
Open accessAbstract
Alzheimer's disease (AD) is the leading cause of dementia in the United States and afflicts >5.7 million Americans in 2018. Therapeutic options remain extremely limited to those that are symptom targeting, while no drugs have been approved for the modification or reversal of the disease itself. Risk factors for AD including aging, the female sex, as well as carrying an APOE4 genotype. These risk factors have been extensively examined in the literature, while less attention has been paid to modifiable risk factors, including lifestyle, and environmental risk factors such as exposures to air pollution and pesticides. This review highlights the most recent data on risk factors in AD and identifies gene by environment interactions that have been investigated. It also provides a suggested framework for a personalized therapeutic approach to AD, by combining genetic, environmental and lifestyle risk factors. Understanding modifiable risk factors and their interaction with non-modifiable factors (age, susceptibility alleles, and sex) is paramount for designing personalized therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an individual’s genetic background has been reported to influence how they respond to environmental exposures or lifestyle factors [269]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [269]
In the citing paper
“Several modifiable risk factors have been associated with AD risk across populations, including educational attainment, obesity, cholesterol levels, social isolation, alcohol consumption, and exposure to pesticides [269, 270]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [269]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–264 of 264
Traumatic brain injury history is associated with earlier age of onset of Alzheimer disease
LoBue, C., Wadsworth, H., Wilmoth, K., Clem, M., Hart, J., Womack, K. B., Didehbani, N., Lacritz, L. H., Rossetti, H. C., & Cullum, C. M. (2017) · The Clinical Neuropsychologist · doi:10.1080/13854046.2016.1257069 · Cited by 90
Zhu, X., Yu, J., Jiang, T., Wang, P., Cao, L., & Tan, L. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8723-8 · Cited by 89
Organochlorine pesticide levels and risk of Alzheimer’s disease in north Indian population
Singh, N., Chhillar, N., Banerjee, B., Bala, K., Basu, M., & Mustafa, M. (2012) · Human & Experimental Toxicology · doi:10.1177/0960327112456315 · Cited by 89
Family History of Alzheimer's Disease and Hippocampal Structure in Healthy People
Donix, M., Burggren, A. C., Suthana, N., Siddarth, P., Ekstrom, A. D., Krupa, A. K., Jones, M., Martin‐Harris, L., Ercoli, L. M., Miller, K. J., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09111575 · Cited by 88
Jellinger, K. A., Paulus, W., Wrocklage, C., & Litvan, I. (2001) · BMC Neurology · doi:10.1186/1471-2377-1-3 · Cited by 86
Introduction to special issue: Overview of Alzheimer's Disease Neuroimaging Initiative
Weiner, M. W., & Veitch, D. P. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.05.007 · Cited by 85
Smoking, Death, and Alzheimer Disease: A Case of Competing Risks
Chang, C.-C. H., Zhao, Y., Lee, C.-W., & Ganguli, M. (2012) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3182420b6e · Cited by 85
Initiative, F. T. A. D. N., Ridge, P. G., Karch, C. M., Hsu, S., Arano, I., Teerlink, C. C., Ebbert, M. T. W., Gonzalez Murcia, J. D., Farnham, J. M., Damato, A. R., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0486-1 · Cited by 83
Popp, J., Lewczuk, P., Kölsch, H., Meichsner, S., Maier, W., Kornhuber, J., Jessen, F., & Lütjohann, D. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07893.x · Cited by 81
Maternal family history is associated with Alzheimer's disease biomarkers
Honea, R. A., Initiative, F. T. A. D. N., Vidoni, E. D., Swerdlow, R. H., & Burns, J. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120676 · Cited by 79
Traumatic brain injury and age at onset of cognitive impairment in older adults
Li, W., Risacher, S. L., McAllister, T. W., & Saykin, A. J. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8093-4 · Cited by 77
Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease
Benseny‐Cases, N., Klementieva, O. L., & Cladera, J. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-5416-4 · Cited by 74
Review: The genetics of A lzheimer's disease; putting flesh on the bones
Medway, C., & Morgan, K. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12101 · Cited by 72
A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease
AESG, Hartl, D., May, P., Gu, W., Mayhaus, M., Pichler, S., Spaniol, C., Glaab, E., Bobbili, D. R., Antony, P. M. A., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0091-8 · Cited by 72
The Role of Cholesterol Metabolism in Alzheimer’s Disease
Sun, J.-H., Yu, J.-T., & Tan, L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8749-y · Cited by 70
Alzheimer's risk variants in the clusterin gene are associated with alternative splicing
Szymanski, M., Wang, R., Bassett, S. S., & Avramopoulos, D. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.17 · Cited by 68
Association of environmental tobacco smoke with dementia and Alzheimer's disease among never smokers
Chen, R. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.09.231 · Cited by 62
Scacchi, R., Gambina, G., Broggio, E., & Corbo, R. M. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4043 · Cited by 58
Statins and their influence on brain cholesterol
Cibičková, L. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.06.007 · Cited by 58
Susceptibility to air pollution in elderly males and females
Boezen, H. M., Vonk, J. M., van der Zee, S. C., Gerritsen, J., Hoek, G., Brunekreef, B., Schouten, J. P., & Postma, D. S. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00076104 · Cited by 57
Role of Family History for Alzheimer Biomarker Abnormalities in the Adult Children Study
Xiong, C. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.208 · Cited by 56
Kalinin, S., González‐Prieto, M., Scheiblich, H., Lisi, L., Kusumo, H., Heneka, M. T., Madrigal, J. L. M., Pandey, S. C., & Feinstein, D. L. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1184-7 · Cited by 55
Genes, the environment and personalized medicine
Carlsten, C., Brauer, M. D., Brinkman, F. S. L., Brook, J. R., Daley, D., McNagny, K. M., Pui, M. M., Royce, D., Takaro, T. K., & Denburg, J. A. (2014) · EMBO Reports · doi:10.15252/embr.201438480 · Cited by 53
Mun, M.-J., Kim, J.-H., Choi, J.-Y., & Jang, W. (2016) · Meta Gene · doi:10.1016/j.mgene.2016.01.001 · Cited by 52
Amyloid-Beta Solubility in the Treatment of Alzheimer’s Disease
Murphy, M. P. (2018) · New England Journal of Medicine · doi:10.1056/nejme1714638 · Cited by 52
The potential applications of Apolipoprotein E in personalized medicine
Villeneuve, S., Brisson, D., Marchant, N. L., & Gaudet, D. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00154 · Cited by 50
Kurata, T., Miyazaki, K., Kozuki, M., Morimoto, N., Ohta, Y., Ikeda, Y., & Abe, K. (2012) · Neurological Research · doi:10.1179/1743132812y.0000000054 · Cited by 49
Traumatic brain injury history and progression from mild cognitive impairment to Alzheimer disease.
LoBue, C., Woon, F. L. M., Rossetti, H. C., Hynan, L. S., Hart, J., & Cullum, C. M. (2018) · Neuropsychology · doi:10.1037/neu0000431 · Cited by 49
Gilbert, M., Snyder, C., Corcoran, C., Norton, M. C., Lyketsos, C. G., & Tschanz, J. T. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214000842 · Cited by 48
Shpanskaya, K. S., Choudhury, K. R., Hostage, C. A., Murphy, K. R., Petrella, J. R., & Doraiswamy, P. M. (2014) · Journal of Neuroradiology · doi:10.1016/j.neurad.2013.11.004 · Cited by 46
Back to the future: Alzheimer's disease heterogeneity revisited
Au, R., Piers, R. J., & Lancashire, L. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.05.006 · Cited by 45
Venkataraman, A. V., Kalk, N. J., Sewell, G. W., Ritchie, C. W., & Lingford-Hughes, A. R. (2016) · Alcohol and Alcoholism · doi:10.1093/alcalc/agw101 · Cited by 45
Aschenbrenner, A. J., Balota, D. A., Gordon, B. A., Ratcliff, R., & Morris, J. C. (2015) · Neuropsychology · doi:10.1037/neu0000222 · Cited by 43
Validating GWAS Variants from Microglial Genes Implicated in Alzheimer’s Disease
dos Santos, L. R., Pimassoni, L. H. S., Sena, G. G. S., Camporez, D., Belcavello, L., Trancozo, M., Morelato, R. L., Errera, F. I. V., Passos‐Bueno, M. R., & Paula, F. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0928-7 · Cited by 42
Panza, F., Seripa, D., Lozupone, M., Solfrizzi, V., Imbimbo, B. P., Barulli, M. R., Tortelli, R., Capozzo, R., Bisceglia, P., Dimitri, A., et al. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1389885 · Cited by 41
Zhang, S., Li, X., Ma, G., Jiang, Y., Liao, M., Feng, R., Zhang, L., Liu, J., Wang, G., Zhao, B., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9098-1 · Cited by 41
Downer, B. G., Zanjani, F. A. K., & Fardo, D. W. (2013) · Alcohol and Alcoholism · doi:10.1093/alcalc/agt144 · Cited by 41
Biological basis for amyloidogenesis in Alzheimer’S disease
Андреева, Т. В., Lukiw, W. J., & Rogaev, E. I. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917020043 · Cited by 38
Hazlett, K. E., Figueroa, C. M., & Nielson, K. A. (2015) · Neuropsychology · doi:10.1037/neu0000181 · Cited by 37
Association between alcohol and Alzheimer's disease
Huang, W., Zhang, X., & Chen, W. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3455 · Cited by 36
Tripodis, Y., Alosco, M. L., Zirogiannis, N., Gavett, B. E., Chaisson, C. E., Martin, B. M., McClean, M. D., Mez, J., Kowall, N. W., & Stern, R. A. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160585 · Cited by 35
Early-Onset Familial Alzheimer Disease
Bird, T. D. (2012) · Cited by 35
Relation between cholesterol levels, statins and Alzheimer's disease in the human population.
Austen, B., Christodoulou, G., & Terry, J. (2002) · PubMed · Cited by 33
Isolated and Joint Effects of Tobacco and Alcohol Consumption on Risk of Alzheimer's Disease
García, A. M., Ramón-Bou, N., & Porta, M. S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1399 · Cited by 33
Gene–Environment Interaction in Alzheimer’s Disease
Singh, N. K., Chhillar, N., Banerjee, B. D., Bala, K., Mukherjee, A. K., Mustafa, M., & Mitrabasu (2012) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317512456067 · Cited by 32
Tyas, S., Pederson, L. L., & Koval, J. J. (2000) · Annals of Epidemiology · doi:10.1016/s1047-2797(00)00061-2 · Cited by 32
Hu, W. H., Tung, Y. C., Zhang, Y., Liu, F., & Iqbal, K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180177 · Cited by 30
A genetics-based biomarker risk algorithm for predicting risk of Alzheimer's disease
Lutz, M. W., Sundseth, S. S., Burns, D. K., Saunders, A. M., Hayden, K. M., Burke, J. R., Welsh‐Bohmer, K. A., Roses, A. D., & Initiative, A. D. N. (2016) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2015.12.002 · Cited by 30
CHRNA7 Polymorphisms and Dementia Risk: Interactions with Apolipoprotein ε4 and Cigarette Smoking
Weng, P., Chen, J., Chen, T., Sun, Y., Wen, L., Yip, P., Chu, Y., & Chen, Y. (2016) · Scientific Reports · doi:10.1038/srep27231 · Cited by 25
Nordestgaard, L. T., Tybjærg‐Hansen, A., Rasmussen, K. L., Nordestgaard, B. G., & Frikke‐Schmidt, R. (2018) · BMC Medicine · doi:10.1186/s12916-018-1029-3 · Cited by 25
Janicki, S. C., Park, N., Cheng, R., Clark, L. N., Lee, J. H., & Schupf, N. (2014) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000355559 · Cited by 25
Age at injury is associated with the long-term cognitive outcome of traumatic brain injuries
Li, W., Risacher, S., McAllister, T., & Saykin, A. (2017) · Alzheimer's & Dementia · doi:10.1016/j.dadm.2017.01.008 · Cited by 23
Clusterin variants are not associated with southern Chinese patients with Alzheimer's disease
Lu, S.-J., Li, H., Sun, Y., Liu, Z., Yang, P., & Wu, Z. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.015 · Cited by 22
Han, Z., Qu, J., Zhao, J., & Zou, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-29450-2 · Cited by 22
Jin, P., Pan, Y., Pan, Z., Xu, J., Lin, M. T., Sun, Z., Chen, M., & Xu, M. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0705-9 · Cited by 21
Statins for Treating Alzheimer's Disease: Truly Ineffective?
Liang, T. B., Li, R., & Cheng, O. (2015) · European Neurology · doi:10.1159/000382128 · Cited by 20
Leclerc, B., & Abulrob, A. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/589308 · Cited by 18
Liu, Z., Chen, H., Li, T., Xu, L., & Du, H. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12028 · Cited by 16
Cholesterol in midlife increases the risk of Alzheimer's disease during an up to 43-year follow-up
Rantanen, K. K., Strandberg, A. Y., Pitkälä, K. H., Tilvis, R. S., Salomaa, V. V., & Strandberg, T. E. (2014) · European Geriatric Medicine · doi:10.1016/j.eurger.2014.05.002 · Cited by 13
Zeng, Y., Chang, W., Shu, C., Ma, L., Huang, Y., Wang, R., Zhang, J., Zhu, C., & McClintock, S. M. (2013) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617713000581 · Cited by 9
Moderate Alcohol Consumption, Apolipoprotein E, and Neuroprotection
Solfrizzi, V. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.35 · Cited by 7
Family History of Alzheimer’s Disease and Cortical Thickness in Patients With Dementia
Ganske, S., Haußmann, R., Gruschwitz, A., Werner, A., Osterrath, A., Baumgaertel, J., Lange, J., Donix, K. L., Linn, J., & Donix, M. (2016) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317516653827 · Cited by 7
Twenty-six–Year Change in Total Cholesterol Levels and Incident Dementia
Stewart, R. J., White, L. R., Xue, Q., & Launer, L. J. (2007) · Archives of Neurology · doi:10.1001/archneur.64.1.103 · Cited by 3
Flagged first, then by citations
4 of the 268 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
“They may achieve this by altering biological pathways and genetic susceptibility, 23,84 – 86 making it challenging to pinpoint a direct cause of clinical pathology in AD.”
BackgroundAstrocytes in heavy metal neurotoxicity and neurodegeneration
Li, B.-M., Xia, M.-S., Zorec, R., Parpura, V., & Verkhratsky, A. (2021) · Brain Research · doi:10.1016/j.brainres.2020.147234 · Cited by 160
Alzheimer’s Disease Detection Using Deep Learning on Neuroimaging: A Systematic Review
Alsubaie, M. G., Luo, S., & Shaukat, K. (2024) · Machine Learning and Knowledge Extraction · doi:10.3390/make6010024 · Cited by 156
Genetic architecture of Alzheimer's disease
Neuner, S. M., TCW, J., & Goate, A. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104976 · Cited by 126
“across populations, including educational attainment, obesity, cholesterol levels, social isolation, alcohol consumption, and exposure to pesticides [269, 270].”
BackgroundIaccarino, L., Joie, R. L., Lesman‐Segev, O. H., Lee, E. Y., Hanna, L., Allen, I. E., Hillner, B. E., Siegel, B. A., Whitmer, R. A., Carrillo, M. C., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.3962 · Cited by 125
Metadata
- Authors
- Eid, A., Mhatre, I., & Richardson, J. R.
- Affiliations
- Florida International University (US)
- Corresponding author
- Richardson, Jason R.
- ORCID
- Richardson, Jason R.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 199
- Pages
- 173-187
- ISSN
- 0163-7258 (ISSN-L)
- PMC
- PMC6827882
- OpenAlex
- W2922392851
- Cited by
- 164
- References
- 268
- Citations by year
- 2026: 21 · 2025: 28 · 2024: 34 · 2023: 20 · 2022: 15 · 2021: 13 · 2020: 24 · 2019: 9
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Pharmacology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (R01ES021800, R01ES026057, R01ES026067-S2, U01NS108956)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Health, Environment, Cognitive Aging
- Keywords
- Alzheimer's disease, gene-environment interaction, modifiable risk factors, lifestyle risk factors, air pollution exposure, pesticide exposure, APOE ε4, sex differences, aging, personalized medicine, precision medicine, dementia
- MeSH terms
- Alzheimer Disease, Animals, Humans, Risk Factors, Precision Medicine, Gene-Environment Interaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
